Výsledky vyhledávání - V.A. Miller

Upřesnit hledání
  1. 1
    "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer

    "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer Autor Christian Grommes, Geoffrey R. Oxnard, Mark G. Kris, V.A. Miller, William Pao, Andrei I. Holodny, Jennifer Clarke, Andrew B. Lassman

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Symptom and Quality of Life Benefit of Afatinib in Advanced Non–Small-Cell Lung Cancer Patients Previously Treated with Erlotinib or Gefitinib: Results of a Randomized Phase IIb/III Trial (LUX-Lung 1)

    Symptom and Quality of Life Benefit of Afatinib in Advanced Non–Small-Cell Lung Cancer Patients Previously Treated with Erlotinib or Gefitinib: Results of a Randomized Phase IIb/II... Autor Vera Hirsh, J. Cadranel, Xiuyu Julie Cong, Diane L. Fairclough, Henrik W. Finnern, Robert M. Lorence, V. A. Miller, Michael Palmer, James Chih‐Hsin Yang

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies

    Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies Autor Jeffrey S. Ross, Siraj M. Ali, K. Wang, Gary A. Palmer, Roman Yelensky, Doron Lipson, V.A. Miller, Deborah A. Zajchowski, Laura K. Shawver, Philip J. Stephens

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Activity of Afatinib/Cetuximab in Patients (PTS) with EGFR Mutant Non-Small Cell Lung Cancer (Nsclc) and Acquired Resistance (Ar) To EGFR Inhibitors

    Activity of Afatinib/Cetuximab in Patients (PTS) with EGFR Mutant Non-Small Cell Lung Cancer (Nsclc) and Acquired Resistance (Ar) To EGFR Inhibitors Autor Y. Y. Janjigian, Egbert F. Smit, Leora Horn, Harry J.M. Groen, D. Ross Camidge, Scott Gettinger, Yali Fu, L. Denis, V.A. Miller, William Pao

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients

    Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients Autor Ilya G. Serebriiskii, Caitlin Connelly, Garrett M. Frampton, Justin Y. Newberg, Matthew Cooke, V. A. Miller, Siraj M. Ali, Jeffrey S. Ross, Elizabeth A. Handorf, Sanjeevani Arora, Christopher H. Lieu, Erica A. Golemis, Joshua E. Meyer

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

    Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer Autor Alexa B. Schrock, Ching Ouyang, Jaideep Sandhu, Ethan S. Sokol, Dexter X. Jin, Jeffrey S. Ross, V.A. Miller, Dean Lim, Idoroenyi Amanam, Joseph Chao, Daniel V.T. Catenacci, M. Cho, Fadi Braiteh, Samuel J. Klempner, Siraj M. Ali, Marwan Fakih

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer

    Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer Autor Jeffrey S. Ross, K Wang, Osama Elkadi, Ashley J. Tarasen, Llewelyn Foulke, Christine E. Sheehan, Geoff Otto, Gary A. Palmer, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Siraj M. Ali, Julia A. Elvin, Deborah Morosini, V.A. Miller, Philip J. Stephens

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

    Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy Autor Z.R. Chalmers, Simak Ali, Robert S. Ohgami, Paulo Vidal Campregher, Garrett M. Frampton, R Yelensky, Julia A. Elvin, Norma Alonzo Palma, Rebecca Erlich, J-A Vergilio, Juliann Chmielecki, Jeff Ross, P. J. Stephens, Róbert Hermann, V. A. Miller, C Miles

    Vydáno 2015
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  9. 9
    HER2 V659 and G660 transmembrane mutations that stabilize homo- and hetero-dimerization are rare oncogenic drivers in lung adenocarcinoma that are clinically responsive to afatinib

    HER2 V659 and G660 transmembrane mutations that stabilize homo- and hetero-dimerization are rare oncogenic drivers in lung adenocarcinoma that are clinically responsive to afatinib Autor S.-H.I. Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Charbel Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, J.S. Ross, P. Stephens, V.A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Inhibiting MEK in MAPK pathway-activated myeloma

    Inhibiting MEK in MAPK pathway-activated myeloma Autor Christoph Heuck, Yogesh Jethava, Rashid Z Khan, Frits van Rhee, Maurizio Zangari, Shweta S. Chavan, Kelly R. Robbins, Scott E. Miller, Aasiya Matin, Meera Mohan, Siraj M. Ali, P. J. Stephens, Jeffrey S. Ross, V.A. Miller, Faith E. Davies, Bart Barlogie, Gareth J. Morgan

    Vydáno 2015
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies

    Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies Autor Jeffrey S. Ross, K Wang, Janne V. Rand, Laurie M. Gay, Marco Presta, Christine E. Sheehan, Siraj M. Ali, Julia A. Elvin, Elaine LaBrecque, Christine N. Hiemstra, Jamie Buell, Geoffrey A. Otto, Roman Yelensky, Doron Lipson, Deborah Morosini, Juliann Chmielecki, V.A. Miller, Phil Stephens

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

    Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies Autor Jeffrey S. Ross, Laurie M. Gay, K. Wang, Jo‐Anne Vergilio, James Suh, Shakti Ramkissoon, Hilary Somerset, Jennifer M. Johnson, Jeffery S. Russell, Siraj M. Ali, Alexa B. Schrock, David Fabrizio, Garrett M. Frampton, V.A. Miller, Philip J. Stephens, Julia A. Elvin, Daniel W. Bowles

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing

    Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing Autor Christine H. Chung, Violeta Beleva Guthrie, David L. Masica, Collin Tokheim, Hyunseok Kang, Jeremy D. Richmon, Nishant Agrawal, Carole Fakhry, Harry Quon, Rathan M. Subramaniam, Zhixiang Zuo, T. Seiwert, Zachary R. Chalmers, Garrett M. Frampton, Siraj M. Ali, Roman Yelensky, Philip J. Stephens, V.A. Miller, Rachel Karchin, Justin A. Bishop

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    <i>ALK</i>Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy

    <i>ALK</i>Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy Autor Jeffrey S. Ross, Siraj M. Ali, Omotayo Fasan, Jared Block, Sumanta K. Pal, Julia A. Elvin, Alexa B. Schrock, James Suh, Sahar Nozad, Sungeun Kim, Hwajeong Lee, Christine E. Sheehan, David Jones, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, V. A. Miller, Philip J. Stephens, Laurie M. Gay

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes

    Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes Autor Jon Chung, Eric M. Sanford, Adrienne Johnson, Samuel J. Klempner, Alexa B. Schrock, Norma Alonzo Palma, Rachel Erlich, Garrett M. Frampton, Zachary R. Chalmers, Jo‐Anne Vergilio, Douglas A. Rubinson, Jiayi Sun, Juliann Chmielecki, Roman Yelensky, James Suh, Doron Lipson, Thomas J. George, Julia A. Elvin, Philip J. Stephens, V.A. Miller, Jeffrey S. Ross, Siraj M. Ali

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias

    Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias Autor Nicole Kucine, Sachie Marubayashi, Neha Bhagwat, Efthymia Papalexi, Priya Koppikar, Marta Sanchez Martin, Lauren Dong, Marty S. Tallman, Elisabeth Paietta, Kai Wang, Jie He, Doron Lipson, Phil Stephens, V. A. Miller, Jacob M. Rowe, Julie Teruya‐Feldstein, Charles G. Mullighan, Adolfo A. Ferrando, Andrei V. Krivtsov, Scott A. Armstrong, Laura Leung, Stefan O. Ochiana, Gabriela Chiosis, Ross L. Levine, Maria Kleppe

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

    Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer Autor Aria Vaishnavi, Marzia Capelletti, Anh T. Le, Severine Kako, Mohit Butaney, Dalia Ercan, Sakshi Mahale, Kurtis D. Davies, Dara L. Aisner, Amanda B. Pilling, Eamon M. Berge, Young Tae Kim, Hidefumi Sasaki, Seung-Il Park, Gregory V. Kryukov, Levi A. Garraway, Peter S. Hammerman, Julia Haas, Steven W. Andrews, Doron Lipson, Philip J. Stephens, V.A. Miller, Marileila Varella‐Garcia, Pasi A. Jänne, Robert C. Doebele

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias

    Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias Autor K Wang, Marta Sánchez-Martín, X Wang, Kristina M. Knapp, Richard P. Koche, Ly Vu, Michelle Nahas, Jie He, Michael Hadler, Eytan M. Stein, Martin S. Tallman, Amy Donahue, Garrett M. Frampton, Doron Lipson, Sarah Roels, P. J. Stephens, Eric M. Sanford, Timothy A Brennan, Geoff Otto, Roman Yelensky, V. A. Miller, Michael G. Kharas, Ross L. Levine, Adolfo A. Ferrando, Scott A. Armstrong, Andrei V. Krivtsov

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker Autor Shweta S. Chavan, Jie He, Ruslana G. Tytarenko, S Deshpande, Pragi Patel, Mark Bailey, Joshua Epstein, Owen Stephens, Niels Weinhold, Nathan Petty, Doug Steward, Leo Rasche, Michael Bauer, Cody Ashby, Erich A. Peterson, Siraj M. Ali, Jeffrey S. Ross, V.A. Miller, P. J. Stephens, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Bart Barlogie, Tariq I. Mughal, Faith E. Davies, Gareth J. Morgan, Brian A. Walker

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

    Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer Autor Jon Chung, Dean C. Pavlick, Ryan J. Hartmaier, Alexa B. Schrock, Lauren Young, Brady Forcier, Pengju Ye, Maren K. Levin, Michael E. Goldberg, Howard A. Burris, Laurie M. Gay, Anthony Hoffman, Philip J. Stephens, Garrett M. Frampton, Doron Lipson, David Nguyen, Shridar Ganesan, B. H. Park, Linda T. Vahdat, Brian Leyland‐Jones, Tariq I. Mughal, Lajos Pusztai, Joyce O’Shaughnessy, V.A. Miller, Jeffrey S. Ross, Siraj M. Ali

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: